IPC
Imperial Pacific Limited
🇦🇺 ASX
💸 FINANCIALS
💰 HIGH DIVIDEND
📈 HIGH PRICE GROWTH
👑 Overview
📈 Performance
💰 Dividends
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
+ 9.53%
Annual Growth
5 years average annual growth
💰
4.83%
Annual dividend yield
Based on the most recent dividend
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
0
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Imperial Pacific Ltd. engages in the business of strategic equity investment in financial services. The principal activities of the Company include strategic equity investment in financial services and the portfolio management of London City Equities Limited. The company provides productive management input to related parties in which it has a strategic equity interest. The firm's subsidiaries include Imperial Pacific Asset Management Pty Ltd and Imperial Pacific Fund Managers Pty Ltd.
📈 Performance
Price History
+113.07%
1M
1Y
10Y
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💰 Dividends
Payouts
💰 Annual Dividend Yield*
4.83%
💰 Annual Dividend Earnings Per $1,000 invested**
$48.28
💰 Most Recent Dividend Franked Percentage Estimate
100.00%
💰 Average Dividend Franked Percentage Estimate
100.00 %
💰 Dividend reinvestment
* Based on the most recent dividend
** Calculated by multiplying the most recent dividend yield by $1,000
Estimate your dividend
If you held
$
of IPC, your last dividend payment(s) would have been:
$ 689.66
on Mon Nov 11 2024
$ 756.66
on Fri Oct 13 2023
*Disclaimer: The information provided in this calculator is only a model to show you how long you need to invest for to achieve your goal, based on several factors, including past performance which is not an indicator of future performance. It is not a prediction and relies on assumptions, such as interest rates, that may vary and change the actual outcome. The results shown are only estimates and are not intended to be relied on when making a financial decision. Consider whether to get advice from a licensed financial adviser before making any financial decision.
Dividend History
1Y
5Y
10Y
Graph
Table
Year
Yearly Dividend Earnings Per Share
Franking Estimate
2024
$0.00
0.00%
2023
$0.06
Infinity%
2022
$0.06
Infinity%
2021
$0.06
Infinity%
2020
$0.06
Infinity%
2019
$0.06
Infinity%
2018
$0.06
Infinity%
2017
$0.06
Infinity%
2016
$0.05
Infinity%
2015
$0.05
100.00%
💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$1.45
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in IPC
0
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
N/A
💵 Average investment amount
N/A
⏰ Last time a customer invested in IPC
N/A
IPC investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
Less than 50k
👶 Age of investors
18 - 25
26 - 34
35 - 90
🙋 Legal gender of investors
Female
Male
Pearlers who invest in IPC also invest in...
Want more shares? Try these...
ImpediMed Ltd. engages in the development and distribution of bioimpedance devices with a focus on medical applications in the fluid status area. The company is headquartered in Brisbane, Queensland and currently employs 83 full-time employees. The company went IPO on 2007-10-24. The firm uses bioimpedance spectroscopy (BIS) technology to generate data to maximize patient health. The firm designs and manufactures medical devices employing bioimpedance spectroscopy (BIS) technologies for use in the noninvasive clinical assessment and monitoring of fluid status and tissue composition. The Company’s SOZO Digital Health Platform is a Food and Drug Administration (FDA)-cleared bioimpedance spectroscopy (BIS) solution for the clinical assessment of lymphedema. SOZO uses its BIS technology to measure and track critical information about the human body to aid clinicians in managing chronic disease and maximizing patient health. Its product SFB7 measures fluid status and tissue composition for clinical and research applications. Its ImpediVET is a single-channel, tetrapolar bioimpedance spectroscopy (BIS) device that measures fluid status and tissue composition for veterinary applications.
🙌 Performance (5Yr p.a)
-13.84%
📊 Share price
$0.06 AUD
🩺 HEALTH CARE
IPD Group Ltd. engages in the servicing industry. The company is headquartered in Sydney, New South Wales. The company went IPO on 2021-12-17. The firm's Products division is engaged in the sale of electrical infrastructure products to customers, including switchboard manufacturers, electrical wholesalers, electrical contractors, power utilities, original equipment manufacturers (OEMs) and system integrators. Within the division there are five categories of products: power distribution, industrial and motor control, automation and industrial communication, power monitoring, and hazardous area equipment. In addition to selling products, it provides a range of value-added services, including custom assembly, sourcing, engineering design, technical compliance, procurement, transport, storage, regulatory management, technical support, packaging, labelling, inventory management and delivery. Its Services division is engaged in provision of services, including installation and commissioning, calibration and testing, maintenance, and repairs, and others.
📊 Share price
$3.80 AUD
🔨 COMMERCIAL SERVICES & SUPPLIES
IPAY.AX was created on 2021-12-13 by BetaShares. The fund's investment portfolio concentrates primarily on total market equity. IPAY.AX aims to track the performance of an Index (before fees and expenses) that provides exposure to a
📊 Share price
$14.19 AUD
💸 FINANCIALS
IPB Petroleum Ltd. is an oil and gas exploration company, which holds interest in the WA-424-P exploration permit project. The company is headquartered in Melbourne, Victoria. The company went IPO on 2013-04-30. The firm has a 100% interest in the petroleum exploration permits located in the Browse Basin: WA-424-P. The Browse Basin is located north of Broome, offshore, Western Australia, and covers an area of approximately 140,000 square kilometers (km2). The WA-424-P permit contains three wells, including Gwydion-1, Caspar-1A and Pryderi-1. The Company’s subsidiaries include IPB WA 424P Pty Ltd and IPB Exploration Pty Ltd.
🙌 Performance (5Yr p.a)
-15.20%
📊 Share price
$0.01 AUD
⚡️ ENERGY